05/18/2026
Join us at the 7th Dermatology Drug Development Summit Europe in Amsterdam! Canfield’s VP of Imaging Endpoint Services, Anthony Melione, will be speaking about how validated imaging tools are advancing dermatology clinical research through:
🔹 High-quality, reproducible imaging that strengthens quality oversight and supports quantitative regulatory endpoints
🔹 Objective, standardized assessments to support efficacy claims
🔹 Leveraging large dermatology datasets and AI to drive broader systemic impact
🔹 Imaging-focused Clinical Outcome Assessments delivered through secure, compliant systems
As imaging continues to play a critical role in dermatology drug development, we look forward to sharing insights on how standardized, data-driven approaches can improve trial confidence and outcomes.